A deprescribing programme aimed to optimise blood glucose-lowering medication in older people with type 2 diabetes mellitus, the OMED2-study: the study protocol for a randomised controlled trial

Peer Review reports

Original Submission
27 Mar 2024	Submitted	Original manuscript
27 Apr 2024	Reviewed	Reviewer Report - Riaz Qureshi
22 May 2024	Author responded	Author comments - Charlotte Andriessen
Resubmission - Version 2
22 May 2024	Submitted	Manuscript version 2
30 May 2024	Reviewed	Reviewer Report - Riaz Qureshi
Resubmission - Version 3
	Submitted	Manuscript version 3
Publishing
14 Jun 2024	Editorially accepted
25 Jul 2024	Article published	10.1186/s13063-024-08249-9

Back to article page